Summary
Although the genome provides information about the somatic genetic changes existing in the tissue and underpins pathology, it is the proteins that do the work of the cell and are functionally responsible for almost all disease processes. Moreover, many diseases such as cancer are a manifestation of deranged cellular protein molecular networks and cell-signaling pathways. These pathways contain a large and growing collection of drug targets, governing cellular survival, proliferation, invasion, and cell death. Thus, the promise of proteomics resides in the study of molecules that extend beyond correlation to causality. The clinical utility of reverse phase protein microarrays, a new technology invented in our laboratory, lies in its ability to generate a functional map of known cell-signaling networks or pathways for an individual patient obtained directly from a biopsy specimen. This patient-specific circuit diagram provides key information that identifies critical nodes or pathways that may serve as drug targets for individualized or combinatorial therapy through the quantification of phosphorylation states of proteins. Using this technique, the entire cellular proteome is immobilized on a substratum with subsequent immunodetection of the phosphorylated, or activated, state of cell-signaling proteins. The results of which pathways are “in use” can then be correlated with biological and clinical information and serve as both a diagnostic and a therapeutic guide: thus providing a “theranostic” endpoint.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Liotta L. A., Espina V., Mehta A. I., et al,. (2003) Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell 3(4), 317–25.
Haab B. B., Dunham M. J., and Brown P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2(2), RESEARCH0004.
Macbeath G. and Schreiber S. L. (2000) Printing proteins as microarrays for high-throughput function determination. Science 289(5485), 1760–3.
Macbeath G. (2002) Protein microarrays and proteomics. Nat Genet 32 (Suppl.) 526–32.
Paweletz C. P., Charboneau L., Bichsel V. E., et al,. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 20(16), 1981–9.
Zhu H. and Snyder M. (2003) Protein chip technology. Curr Opin Chem Biol 7(1), 55–63.
Wilson D. S. and Nock S. (2003) Recent developments in protein microarray technology. Angew Chem Int Ed Engl 42(5), 494–500.
Templin M. F., Stoll D., Schrenk M., et al,. (2002) Protein microarray technology. Trends Biotechnol 20(4), 160–6.
Schaeferling M., Schiller S., Paul H., et al,. (2002) Application of self-assembly techniques in the design of biocompatible protein microarray surfaces. Electrophoresis 23(18), 3097–105.
Weng S., Gu K., Hammond P. W., et al,. (2002) Gene rating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology. Proteomics 2(1), 48–57.
Petach H. and Gold L. (2002) Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr Opin Biotechnol 13, 309–314.
Lal S. P., Christopherson R. I., and Dos Remedios C. G. (2002) Antibody arrays: An embryonic but rapidly growing technology. Drug Discov Today 7(Suppl. 18), S143–9.
Humphery-Smith I., Wischerhoff E., and Hashimoto R. (2002) Protein arrays for assessment of target selectivity. Drug Discovery World 4(1), 17–27.
Bobrow M. N., Harris T. D., Shaughnessy K. J., and Litt G. J. (1989) Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 125(1–2), 279–85.
Bobrow M. N., Shaughnessy K. J., and Litt G. J. (1991) Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods 137(1), 103–12.
Hunyady B., Krempels K., Harta G., and Mezey E. (1996) Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem 44(12), 1353–62.
King G., Payne S., Walker F., and Murray G. I. (1997) A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J Pathol 183(2), 237–41.
Petricoin E., Wulfkuhle J., Espina V., and Liotta L. A. (2004) Clinical proteomics: Revolutionizing disease detection and patient tailoring therapy. J Proteome Res 3(2), 209–17.
Grubb R. L., Calvert V. S., Wulkuhle J. D., et al,. (2003) Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 3(11), 2142–6.
Wulfkuhle J. D., Aquino J. A., Calvert V. S., et al,. (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics. 3(11), 2085–90.
Liotta L. A., Kohn E. C., and Petricoin E. F. (2001) Clinical proteomics: Personalized molecular medicine. JAMA 286(18), 2211–4.
Petricoin E. F., Zoon K. C., Kohn E. C., Barrett J. C., and Liotta L. A. (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov. 1(9), 683–95.
Wulfkuhle J. D., Edmiston K. H., Liotta L. A., and Petricoin E. F. (2006) Technology Insight: Pharmacoproteomics for cancer-promises of patient-tailored medicine using protein microarrays. Nat Clin Pract Oncol 3(5):256–68.
Berggren K., Steinberg T. H., Lauber W. M., et al,. (1999) A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supports. Anal Biochem 276(2), 129–43.
Tonkinson J. L. and Stillman B. A. (2002) Nitrocellulose: A tried and true polymer finds utility as a post-genomic substrate. Front Biosci 7, c1–12.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Espina, V., Wulfkuhle, J., Calvert, V.S., Liotta, L.A., Petricoin, E.F. (2008). Reverse Phase Protein Microarrays for Theranostics and Patient-Tailored Therapy. In: Liu, B.CS., Ehrlich, J.R. (eds) Tissue Proteomics. Methods in Molecular Biology™, vol 441. Humana Press. https://doi.org/10.1007/978-1-60327-047-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-047-2_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-679-5
Online ISBN: 978-1-60327-047-2
eBook Packages: Springer Protocols